
Shift Bioscience
Operator of a biotechnology company intended to develop simulation-guided cell rejuvenation therapies to address the diseases of aging. The company utilizes simulation-guided techniques to discover ge...
Valuation
$30.5M
Latest known
Share Price
N/A
Total Raised
$17.5M
Last Round
N/A